Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 496 (ZNF496) is a human protein-coding gene encoding a transcription factor of the zinc finger family, characterized by KRAB and SCAN domains, with 587 amino acids in its full-length form[1][2][4]. It binds DNA in a sequence-specific manner, both activating and repressing gene expression, and is functionally associated with regulation of transcription by RNA polymerase II[1][4]. ZNF496 interacts with JARID2, a regulator of neuronal differentiation, and mutations in ZNF496 (notably truncations affecting the C2H2 domain) have been identified as pathogenic in neurodevelopmental disorders, including intellectual disability and developmental delay[2]. While ZNF496 is genetically associated with Sotos syndrome and Weaver syndrome, it is not considered a direct therapeutic target and has no established role in drug development or patient biomarker usage[1][2][4].
none known (no approved drugs or therapeutics acting via this target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 496 (ZNF496).